Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.74 USD | -3.34% | +4.10% | +70.76% |
19/04 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
28/03 | Truist Securities Initiates Coverage on Merus With Buy Rating, $69 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.76% | 2.84B | |
+8.93% | 105B | |
-0.65% | 104B | |
+5.79% | 22.94B | |
-12.12% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.19% | 16.96B | |
+7.74% | 14.16B | |
+38.02% | 12.63B |
- Stock Market
- Equities
- MRUS Stock
- News Merus N.V.
- Merus Prices Offering at $28.5/Share, Expects $110 Million Gross Proceeds